Generating patient-derived clinical metadata and biospecimen samples Predicting viable biomarkers and therapeutic candidates Production of small molecules via cell-free expression High throughput immune-profiling assays Ana Vega Rodríguez, PhD Ayin Vala, MS Claire Toney, BS Dora Yu, PhD Jesus Barajas, PhD Kareem Barghouti, MBA Lanying Ma, PhD Mark Ashwell, PhD Nehal Hedge Nora Fritz, MBA Peter McCaffrey, MD Riccardo Guidi, PhD Subramanya Rao, PhD Alex Cogdill, PhD Stephen Nayfach, PhD Tomer Altman, PhD Elaine Stracker, JD, PhD Grazia Piizzi, PhD Ken Blount, PhD Kovi Bessoff, MD, PhD Mohamed Donia, PhD Mohan Iyer, MBA Milad Alucozai, MS, MPH Nadim Ajami, PhD Phil Jones, PhD Wasim Malik, PhD 280 Utah Ave. South San Francisco, CA (650) 479-5539 info@pragmabio.com
Our Process
Multi-omic Data
AI
Synthetic Biology
Functional Screening
We are using proprietary methods in genomic sequencing, artificial intelligence, and synthetic biology to discover biomarkers and novel therapeutics for the most challenging immunologic disorders.
Team
Research Scientist
Co-founder, Chief AI Officer
Research Assistant
Scientist
Head of Natural Product Discovery
Co-founder, CEO
Senior Bioinformatics Scientist
Head of Chemistry
Research Assistant
Strategy and Operations Manager
Co-founder, CTO
Head of Immunology Research
Scientist
Cancer Immunology
Bioinformatics
Bioinformatics
Advisors
Former EVP & General Counsel at Pharmacyclics
Former Executive Director at Merck
CSO Rebiotix
Co-founder
Associate Professor, Princeton University
General Partner, SOSV/IndieBio
Serial Entrepreneur, Advisor to AstraZeneca
Executive Director of Microbiome at MD Anderson
VP of Therapeutic Discovery at MD Anderson
Managing Partner at Iaso, Former CDO at Roivant
Supported By
Partners
Contact Us
LOCATION
PHONE
EMAIL
